236 related articles for article (PubMed ID: 20613485)
1. MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.
Dent P; Yacoub A; Hamed HA; Park MA; Dash R; Bhutia SK; Sarkar D; Gupta P; Emdad L; Lebedeva IV; Sauane M; Su ZZ; Rahmani M; Broaddus WC; Young HF; Lesniak M; Grant S; Curiel DT; Fisher PB
Anticancer Drugs; 2010 Sep; 21(8):725-31. PubMed ID: 20613485
[TBL] [Abstract][Full Text] [Related]
2. The development of MDA-7/IL-24 as a cancer therapeutic.
Dent P; Yacoub A; Hamed HA; Park MA; Dash R; Bhutia SK; Sarkar D; Wang XY; Gupta P; Emdad L; Lebedeva IV; Sauane M; Su ZZ; Rahmani M; Broaddus WC; Young HF; Lesniak MS; Grant S; Curiel DT; Fisher PB
Pharmacol Ther; 2010 Nov; 128(2):375-84. PubMed ID: 20732354
[TBL] [Abstract][Full Text] [Related]
3. MDA-7/IL-24 regulates proliferation, invasion and tumor cell radiosensitivity: a new cancer therapy?
Dent P; Yacoub A; Grant S; Curiel DT; Fisher PB
J Cell Biochem; 2005 Jul; 95(4):712-9. PubMed ID: 15880678
[TBL] [Abstract][Full Text] [Related]
4. mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic.
Fisher PB; Gopalkrishnan RV; Chada S; Ramesh R; Grimm EA; Rosenfeld MR; Curiel DT; Dent P
Cancer Biol Ther; 2003; 2(4 Suppl 1):S23-37. PubMed ID: 14508078
[TBL] [Abstract][Full Text] [Related]
5. Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.
Fisher PB; Sarkar D; Lebedeva IV; Emdad L; Gupta P; Sauane M; Su ZZ; Grant S; Dent P; Curiel DT; Senzer N; Nemunaitis J
Toxicol Appl Pharmacol; 2007 Nov; 224(3):300-7. PubMed ID: 17208263
[TBL] [Abstract][Full Text] [Related]
6. Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.
Emdad L; Bhoopathi P; Talukdar S; Pradhan AK; Sarkar D; Wang XY; Das SK; Fisher PB
Semin Cancer Biol; 2020 Nov; 66():140-154. PubMed ID: 31356866
[TBL] [Abstract][Full Text] [Related]
7. mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine.
Gupta P; Su ZZ; Lebedeva IV; Sarkar D; Sauane M; Emdad L; Bachelor MA; Grant S; Curiel DT; Dent P; Fisher PB
Pharmacol Ther; 2006 Sep; 111(3):596-628. PubMed ID: 16464504
[TBL] [Abstract][Full Text] [Related]
8. Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24.
Emdad L; Lebedeva IV; Su ZZ; Gupta P; Sauane M; Dash R; Grant S; Dent P; Curiel DT; Sarkar D; Fisher PB
Cancer Biol Ther; 2009 Mar; 8(5):391-400. PubMed ID: 19276652
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients.
Tong AW; Nemunaitis J; Su D; Zhang Y; Cunningham C; Senzer N; Netto G; Rich D; Mhashilkar A; Parker K; Coffee K; Ramesh R; Ekmekcioglu S; Grimm EA; van Wart Hood J; Merritt J; Chada S
Mol Ther; 2005 Jan; 11(1):160-72. PubMed ID: 15585417
[TBL] [Abstract][Full Text] [Related]
10. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF.
Pradhan AK; Bhoopathi P; Talukdar S; Scheunemann D; Sarkar D; Cavenee WK; Das SK; Emdad L; Fisher PB
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5687-5692. PubMed ID: 30842276
[TBL] [Abstract][Full Text] [Related]
11. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells.
Su Z; Emdad L; Sauane M; Lebedeva IV; Sarkar D; Gupta P; James CD; Randolph A; Valerie K; Walter MR; Dent P; Fisher PB
Oncogene; 2005 Nov; 24(51):7552-66. PubMed ID: 16044151
[TBL] [Abstract][Full Text] [Related]
12. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis.
Sauane M; Su ZZ; Dash R; Liu X; Norris JS; Sarkar D; Lee SG; Allegood JC; Dent P; Spiegel S; Fisher PB
J Cell Physiol; 2010 Mar; 222(3):546-55. PubMed ID: 19937735
[TBL] [Abstract][Full Text] [Related]
13. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study.
Cunningham CC; Chada S; Merritt JA; Tong A; Senzer N; Zhang Y; Mhashilkar A; Parker K; Vukelja S; Richards D; Hood J; Coffee K; Nemunaitis J
Mol Ther; 2005 Jan; 11(1):149-59. PubMed ID: 15585416
[TBL] [Abstract][Full Text] [Related]
14. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
Lebedeva IV; Emdad L; Su ZZ; Gupta P; Sauane M; Sarkar D; Staudt MR; Liu SJ; Taher MM; Xiao R; Barral P; Lee SG; Wang D; Vozhilla N; Park ES; Chatman L; Boukerche H; Ramesh R; Inoue S; Chada S; Li R; De Pass AL; Mahasreshti PJ; Dmitriev IP; Curiel DT; Yacoub A; Grant S; Dent P; Senzer N; Nemunaitis JJ; Fisher PB
Int J Oncol; 2007 Nov; 31(5):985-1007. PubMed ID: 17912425
[TBL] [Abstract][Full Text] [Related]
15. Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways.
Sauane M; Lebedeva IV; Su ZZ; Choo HT; Randolph A; Valerie K; Dent P; Gopalkrishnan RV; Fisher PB
Cancer Res; 2004 May; 64(9):2988-93. PubMed ID: 15126330
[TBL] [Abstract][Full Text] [Related]
16. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
Lebedeva IV; Su ZZ; Sarkar D; Gopalkrishnan RV; Waxman S; Yacoub A; Dent P; Fisher PB
Oncogene; 2005 Jan; 24(4):585-96. PubMed ID: 15580305
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic aspects of mda-7/IL-24 cancer cell selectivity analysed via a bacterial fusion protein.
Sauane M; Gopalkrishnan RV; Choo HT; Gupta P; Lebedeva IV; Yacoub A; Dent P; Fisher PB
Oncogene; 2004 Oct; 23(46):7679-90. PubMed ID: 15334067
[TBL] [Abstract][Full Text] [Related]
18. mda-7 (IL-24): signaling and functional roles.
Sarkar D; Su ZZ; Lebedeva IV; Sauane M; Gopalkrishnan RV; Dent P; Fisher PB
Biotechniques; 2002 Oct; Suppl():30-9. PubMed ID: 12395925
[TBL] [Abstract][Full Text] [Related]
19. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
[TBL] [Abstract][Full Text] [Related]
20. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner.
Su ZZ; Lebedeva IV; Sarkar D; Gopalkrishnan RV; Sauane M; Sigmon C; Yacoub A; Valerie K; Dent P; Fisher PB
Oncogene; 2003 Feb; 22(8):1164-80. PubMed ID: 12606943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
